1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Primary Hyperparathyroidism Global Clinical Trials Review, H1, 2014

Primary Hyperparathyroidism Global Clinical Trials Review, H1, 2014

Summary

GlobalData's clinical trial report, “Primary Hyperparathyroidism Global Clinical Trials Review, H1, 2014" provides data on the Primary Hyperparathyroidism clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Primary Hyperparathyroidism. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Primary Hyperparathyroidism. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Primary Hyperparathyroidism Global Clinical Trials Review, H1, 2014
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Introduction 5
Primary Hyperparathyroidism 5
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Five Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Countries Contributing to Clinical Trials in Middle East and Africa 12
Clinical Trials by G7 Countries: Proportion of Primary Hyperparathyroidism to Metabolic Disorders Clinical Trials 13
Clinical Trials by Phase in G7 Countries 14
Clinical Trials in G7 Countries by Trial Status 15
Clinical Trials by E7 Countries: Proportion of Primary Hyperparathyroidism to Metabolic Disorders Clinical Trials 16
Clinical Trials by Phase 17
In Progress Trials by Phase 18
Clinical Trials by Trial Status 19
Clinical Trials by End Point Status 20
Subjects Recruited Over a Period of Time 21
Clinical Trials by Sponsor Type 22
Prominent Sponsors 23
Top Companies Participating in Primary Hyperparathyroidism Therapeutics Clinical Trials 24
Prominent Drugs 25
Clinical Trial Profiles 26
Clinical Trial Overview of Top Companies 26
Amgen Inc. 26
Clinical Trial Overview of Amgen Inc. 26
Kirin Holdings Company, Limited 27
Clinical Trial Overview of Kirin Holdings Company, Limited 27
Clinical Trial Overview of Top Institutes / Government 28
Columbia University 28
Clinical Trial Overview of Columbia University 28
Medical University of Vienna 29
Clinical Trial Overview of Medical University of Vienna 29
Postgraduate Institute of Medical Education and Research 30
Clinical Trial Overview of Postgraduate Institute of Medical Education and Research 30
Karolinska University Hospital 31
Clinical Trial Overview of Karolinska University Hospital 31
Rambam Health Care Campus 32
Clinical Trial Overview of Rambam Health Care Campus 32
HaEmek Medical Center 33
Clinical Trial Overview of HaEmek Medical Center 33
The Medical University of Graz 34
Clinical Trial Overview of The Medical University of Graz 34
Kobe University 35
Clinical Trial Overview of Kobe University 35
The National Institute of Diabetes and Digestive and Kidney Diseases 36
Clinical Trial Overview of The National Institute of Diabetes and Digestive and Kidney Diseases 36
Nantes University Hospital 37
Clinical Trial Overview of Nantes University Hospital 37
Five Key Clinical Profiles 38
Appendix 79
Abbreviations 79
Definitions 79
Research Methodology 80
Secondary Research 80
About GlobalData 81
Contact Us 81
Disclaimer 81
Source 81

List of Tables
Primary Hyperparathyroidism Therapeutics, Global, Clinical Trials by Region, 2014* 6
Primary Hyperparathyroidism Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Primary Hyperparathyroidism Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Primary Hyperparathyroidism Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014* 9
Primary Hyperparathyroidism Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 10
Primary Hyperparathyroidism Therapeutics Clinical Trials, North America, Top Countries, 2014* 11
Primary Hyperparathyroidism Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 12
Proportion of Primary Hyperparathyroidism to Metabolic Disorders Clinical Trials, G7 Countries (%), 2014* 13
Primary Hyperparathyroidism Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 14
Primary Hyperparathyroidism Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 15
Proportion of Primary Hyperparathyroidism to Metabolic Disorders Clinical Trials, E7 Countries (%), 2014* 16
Primary Hyperparathyroidism Therapeutics, Global, Clinical Trials by Phase, 2014* 17
Primary Hyperparathyroidism Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 18
Primary Hyperparathyroidism Therapeutics, Global, Clinical Trials by Trial Status, 2014* 19
Primary Hyperparathyroidism Therapeutics Clinical Trials, Global, by End Point Status, 2014* 20
Primary Hyperparathyroidism Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 21
Primary Hyperparathyroidism Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 22
Primary Hyperparathyroidism Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 23
Primary Hyperparathyroidism Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 24
Primary Hyperparathyroidism Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 25
Primary Hyperparathyroidism Therapeutics Clinical Trials Market, Global, Clinical Trials by Amgen Inc., 2014* 26
Primary Hyperparathyroidism Therapeutics Clinical Trials Market, Global, Clinical Trials by Kirin Holdings Company, Limited, 2014* 27
Primary Hyperparathyroidism Therapeutics Clinical Trials Market, Global, Clinical Trials by Columbia University, 2014* 28
Primary Hyperparathyroidism Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical University of Vienna, 2014* 29
Primary Hyperparathyroidism Therapeutics Clinical Trials Market, Global, Clinical Trials by Postgraduate Institute of Medical Education and Research, 2014* 30
Primary Hyperparathyroidism Therapeutics Clinical Trials Market, Global, Clinical Trials by Karolinska University Hospital, 2014* 31
Primary Hyperparathyroidism Therapeutics Clinical Trials Market, Global, Clinical Trials by Rambam Health Care Campus, 2014* 32
Primary Hyperparathyroidism Therapeutics Clinical Trials Market, Global, Clinical Trials by HaEmek Medical Center, 2014* 33
Primary Hyperparathyroidism Therapeutics Clinical Trials Market, Global, Clinical Trials by The Medical University of Graz, 2014* 34
Primary Hyperparathyroidism Therapeutics Clinical Trials Market, Global, Clinical Trials by Kobe University, 2014* 35
Primary Hyperparathyroidism Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Diabetes and Digestive and Kidney Diseases, 2014* 36
Primary Hyperparathyroidism Therapeutics Clinical Trials Market, Global, Clinical Trials by Nantes University Hospital, 2014* 37

List of Figures
Primary Hyperparathyroidism Therapeutics, Global, Clinical Trials by Region (%), 2014* 6
Primary Hyperparathyroidism Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Primary Hyperparathyroidism Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Primary Hyperparathyroidism Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2014* 9
Primary Hyperparathyroidism Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 10
Proportion of Primary Hyperparathyroidism to Metabolic Disorders Clinical Trials, G7 Countries (%), 2014* 13
Primary Hyperparathyroidism Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 14
Primary Hyperparathyroidism Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 15
Proportion of Primary Hyperparathyroidism to Metabolic Disorders Clinical Trials, E7 Countries (%), 2014* 16
Primary Hyperparathyroidism Therapeutics, Global, Clinical Trials by Phase (%), 2014* 17
Primary Hyperparathyroidism Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 18
Primary Hyperparathyroidism Therapeutics, Global, Clinical Trials by Trial Status, 2014* 19
Primary Hyperparathyroidism Therapeutics Clinical Trials, Global, by End Point Status, 2014* 20
Primary Hyperparathyroidism Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 21
Primary Hyperparathyroidism Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 22
Primary Hyperparathyroidism Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 23
Primary Hyperparathyroidism Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 24
Primary Hyperparathyroidism Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 25
GlobalData Methodology 80

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.